Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
Not yet recruiting · NCT06376396 · Registry updated 2024-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis | Central Nervous System Helminthiasis, Central Nervous System Parasitic Infections, Cestode infectious disease, Disease Attributes, Infections, Neglected Diseases, Neurocysticercosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, central nervous system infectious disorder, cysticercosis, epilepsy, helminthiasis, nervous system disorder, parasitic infectious disease, taeniasis | Not yet recruiting | Phase 4 | 2024-04-23 | NCT06376396 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||